These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2260855

  • 21. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
    Kitaoka S, Shiota G, Kawasaki H.
    Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
    [Abstract] [Full Text] [Related]

  • 22. Elevated levels of soluble interleukin-2 receptor in serum of patients with hematological or non-hematological malignancies.
    Nakase K, Tsuji K, Tamaki S, Tanigawa M, Ikeda T, Miyanishi E, Shiku H.
    Cancer Detect Prev; 2005; 29(3):256-9. PubMed ID: 15899555
    [Abstract] [Full Text] [Related]

  • 23. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A, Schiffman MH, Tsukui T, Swanson CA, Lucci J, Scott DR, Glass AG, Rush BB, Lorincz AT, Corrigan A, Burk RD, Helgesen K, Houghten RA, Sherman ME, Kurman RJ, Berzofsky JA, Kramer TR.
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [Abstract] [Full Text] [Related]

  • 24. Effect of immunosuppressive cladribine treatment on serum leucocytes system in two-year clinical trial in patients with chronic progressive multiple sclerosis.
    Janiec K, Wajgt A, Kondera-Anasz Z.
    Med Sci Monit; 2001 Oct; 7(1):93-8. PubMed ID: 11208501
    [Abstract] [Full Text] [Related]

  • 25. [Relation between the clinical and cerebrospinal fluid parameters in multiple sclerosis, with special reference to subjects without oligoclonal IgG in the cerebrospinal fluid].
    Poloni M, Rocchelli B, Mazzarello P, Delodovici M.
    Riv Neurol; 1981 Oct; 51(2):69-80. PubMed ID: 7244541
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Soluble receptors of cytokines in sera of patients with systemic sclerosis--clinical correlation].
    Lis AD, Brzezińska-Wcisło LA.
    Wiad Lek; 2003 Oct; 56(11-12):532-6. PubMed ID: 15058159
    [Abstract] [Full Text] [Related]

  • 28. CD4 T cell activation and disease activity at onset of multiple sclerosis.
    Jensen J, Langkilde AR, Fenst C, Nicolaisen MS, Roed HG, Christiansen M, Sellebjerg F.
    J Neuroimmunol; 2004 Apr; 149(1-2):202-9. PubMed ID: 15020081
    [Abstract] [Full Text] [Related]

  • 29. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
    Chowdhury SA, Lin J, Sadiq SA.
    Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity.
    Yosipovitch G, Shohat B, Bshara J, Wysenbeek A, Weinberger A.
    Isr J Med Sci; 1995 Jun; 31(6):345-8. PubMed ID: 7607852
    [Abstract] [Full Text] [Related]

  • 32. The relationship between levels of cerebrospinal fluid myelin basic protein and IgG measurements in patients with multiple sclerosis.
    Warren KG, Catz I.
    Ann Neurol; 1985 May; 17(5):475-80. PubMed ID: 2408558
    [Abstract] [Full Text] [Related]

  • 33. [The level of soluble interleukin 2 receptor in esophageal carcinoma patients before and after radiotherapy].
    Liu X, An H, Jiang Y.
    Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):97-9. PubMed ID: 7656815
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The relationship of interleukin-2 and soluble interleukin-2 receptors to intrathecal immunoglobulin synthesis in patients with multiple sclerosis.
    Sharief MK, Hentges R, Thompson EJ.
    J Neuroimmunol; 1991 Apr; 32(1):43-51. PubMed ID: 2002090
    [Abstract] [Full Text] [Related]

  • 36. Soluble IL-2 receptor in patients with primary nephrotic syndrome.
    Ohno I, Gomi H, Matsuda H, Nakano H, Matsumoto H, Kodama K, Shibasaki T, Ishimoto F, Sakai O.
    Nihon Jinzo Gakkai Shi; 1991 May; 33(5):483-9. PubMed ID: 1895547
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Soluble interleukin-2 receptor levels in cerebrospinal fluid of patients with acute lymphocytic leukemia or with non-Hodgkin's lymphoma.
    Chang CS, Liu HW, Lin SF, Chen TP.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 May; 22(2):132-7. PubMed ID: 2605973
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.